Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (15)

2024

  1. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

    The Lancet Neurology, Vol. 23, Núm. 3, pp. 243-255

2023

  1. Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

    Neurologia, Vol. 38, pp. S22-S30

  2. Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

    Contemporary Clinical Trials, Vol. 134

2022

  1. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

2021

  1. Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

    BMC Neurology, Vol. 21, Núm. 1

  2. Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey

    BMC Family Practice, Vol. 22, Núm. 1

2020

  1. Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

    Haematologica

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2015

  1. Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma

    Haematologica

2014

  1. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

    Nature Biotechnology, Vol. 32, Núm. 9, pp. 903-914

2013

  1. Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma

    Journal of Clinical Oncology

2012

  1. Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 16

2011

  1. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

    European Respiratory Journal, Vol. 38, Núm. 4, pp. 797-803

2005

  1. FTY720 inhibits TH1-mediated allogeneic humoral immune response

    Transplantation Proceedings

  2. Protection of mouse small bowel allografts by FTY720 and costimulation blockade

    Transplantation, Vol. 79, Núm. 12, pp. 1703-1710